Patents by Inventor Robert Rastall

Robert Rastall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200197452
    Abstract: The present invention relates to a symbiotic composition comprising a probiotic bacterial strain and a prebiotic growth medium which is specific to the growth of the probiotic bacterial strain, wherein the bacterial strain is capable of producing the same growth medium by reverse enzyme reaction. The present invention also relates to methods of producing and screening for such compositions.
    Type: Application
    Filed: February 3, 2020
    Publication date: June 25, 2020
    Inventors: Stephen Patrick O'HARA, Robert Rastall
  • Patent number: 10548927
    Abstract: The present invention relates to a synbiotic composition comprising a probiotic bacterial strain and a prebiotic growth medium which is specific to the growth of the probiotic bacterial strain, wherein the bacterial strain is capable of producing the same growth medium by reverse enzyme reaction. The present invention also relates to methods of producing and screening for such compositions.
    Type: Grant
    Filed: November 5, 2014
    Date of Patent: February 4, 2020
    Inventors: Stephen Patrick O'Hara, Robert Rastall
  • Patent number: 10493093
    Abstract: The present invention relates to a prebiotic composition comprising a microbially produced oligosaccharide, wherein the oligosaccharide is characterized by being selective for a pre-determined probiotic bacterial strain and also capable of being produced by the pre-determined probiotic bacteria by reverse enzyme action. The present invention also relates to methods of screening a composition suitable for use as a prebiotic and methods for screening of prebiotics for incorporation into synbiotic formulations.
    Type: Grant
    Filed: February 21, 2018
    Date of Patent: December 3, 2019
    Inventors: Stephen Patrick O'Hara, Robert Rastall
  • Publication number: 20180177817
    Abstract: The present invention relates to a prebiotic composition comprising a microbially produced oligosaccharide, wherein the oligosaccharide is characterised by being selective for a pre-determined probiotic bacterial strain and also capable of being produced by the pre-determined probiotic bacteria by reverse enzyme action. The present invention also relates to methods of screening a composition suitable for use as a prebiotic and methods for screening of prebiotics for incorporation into synbiotic formulations.
    Type: Application
    Filed: February 21, 2018
    Publication date: June 28, 2018
    Inventors: Stephen Patrick O'HARA, Robert RASTALL
  • Patent number: 9913857
    Abstract: The present invention relates to a prebiotic composition comprising a microbially produced oligosaccharide, wherein the oligosaccharide is characterized by being selective for a pre-determined probiotic bacterial strain and also capable of being produced by the pre-determined probiotic bacteria by reverse enzyme action. The present invention also relates to methods of screening a composition suitable for use as a prebiotic and methods for screening of prebiotics for incorporation into synbiotic formulations.
    Type: Grant
    Filed: November 5, 2014
    Date of Patent: March 13, 2018
    Assignee: Optibiotix Limited
    Inventors: Stephen Patrick O'Hara, Robert Rastall
  • Publication number: 20160271190
    Abstract: The present invention relates to a synbiotic composition comprising a probiotic bacterial strain and a prebiotic growth medium which is specific to the growth of the probiotic bacterial strain, wherein the bacterial strain is capable of producing the same growth medium by reverse enzyme reaction. The present invention also relates to methods of producing and screening for such compositions.
    Type: Application
    Filed: November 5, 2014
    Publication date: September 22, 2016
    Inventors: Stephen Patrick O'HARA, Robert RASTALL
  • Publication number: 20160263144
    Abstract: The present invention relates to a prebiotic composition comprising a microbially produced oligosaccharide, wherein the oligosaccharide is characterised by being selective for a pre-determined probiotic bacterial strain and also capable of being produced by the pre-determined probiotic bacteria by reverse enzyme action. The present invention also relates to methods of screening a composition suitable for use as a prebiotic and methods for screening of prebiotics for incorporation into synbiotic formulations.
    Type: Application
    Filed: November 5, 2014
    Publication date: September 15, 2016
    Inventors: Stephen Patrick O'HARA, Robert RASTALL
  • Patent number: 8557320
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Grant
    Filed: September 4, 2012
    Date of Patent: October 15, 2013
    Assignee: Mead Johnson Nutrition Company
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Publication number: 20120328585
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Application
    Filed: September 4, 2012
    Publication date: December 27, 2012
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Patent number: 8313789
    Abstract: A method of promoting the growth of beneficial bacteria in the gut of a human in need thereof, which involves administering to a human a composition containing an effective amount of Ara-(1-5)-(Ara)n-(1-5)-Ara as a prebiotic, where n=0-18.
    Type: Grant
    Filed: May 26, 2010
    Date of Patent: November 20, 2012
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Arland T. Hotchkiss, Alberto Nunez, Robert A. Rastall, Glenn R. Gibson
  • Patent number: 8277863
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: October 2, 2012
    Assignee: Mead Johnson Nutrition Company
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Patent number: 8021708
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Grant
    Filed: February 12, 2009
    Date of Patent: September 20, 2011
    Assignee: Mead Johnson Nutrition Company
    Inventors: Byron W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Publication number: 20110021417
    Abstract: The present invention concerns compositions comprising a saccharide for the inhibition of pathogen adhesion to mammalian cells.
    Type: Application
    Filed: September 1, 2010
    Publication date: January 27, 2011
    Inventors: Jonathan Robert RHOADES, Robert Rastall, Glenn R. Gibson
  • Publication number: 20100316766
    Abstract: A method of promoting the growth of beneficial bacteria in the gut of a human in need thereof, which involves administering to a human a composition containing an effective amount of Ara-(1-5)-(Ara)n-(1-5)-Ara as a prebiotic, where n=0-18.
    Type: Application
    Filed: May 26, 2010
    Publication date: December 16, 2010
    Inventors: Arland T. Hotchkiss, Alberto Nunez, Robert A. Rastall, Glenn R. Gibson
  • Patent number: 7842678
    Abstract: The present invention concerns compositions comprising a saccharide for the inhibition of pathogen adhesion to mammalian cells.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: November 30, 2010
    Assignee: Nestec S.A.
    Inventors: Jonathan R Rhoades, Robert Rastall, Glenn R. Gibson
  • Publication number: 20090311379
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Application
    Filed: July 2, 2009
    Publication date: December 17, 2009
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Patent number: 7572474
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Grant
    Filed: June 30, 2005
    Date of Patent: August 11, 2009
    Assignee: Mead Johnson Nutrition Company
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glen R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Publication number: 20090176734
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Application
    Filed: February 12, 2009
    Publication date: July 9, 2009
    Applicant: Mead Johnson & Co.
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Publication number: 20070196890
    Abstract: A method for evaluating or quantifying the prebiotic capability of a fiber or for identifying a prebiotic substance, which comprises (a) a step of evaluating or quantifying the effect by the tested fiber or substance on the growth and/or modification of faecal bacterial population, and (b) a step of quantifying at least one product resulting from the fermentation of the tested fiber or substance and/or a step of quantifying the rate of assimilation of the tested fiber or substance.
    Type: Application
    Filed: October 1, 2004
    Publication date: August 23, 2007
    Inventors: Jelena Vulevic, Glenn Gibson, Robert Rastall
  • Publication number: 20060287276
    Abstract: The present invention concerns compositions comprising a saccharide for the inhibition of pathogen adhesion to mammalian cells.
    Type: Application
    Filed: September 17, 2004
    Publication date: December 21, 2006
    Inventors: Jonathan Rhoades, Robert Rastall, Robert Rastall